Getting your Trinity Audio player ready… Cuba is using the humanized monoclonal antibody Itolizumab within the COVID-19 protocol for patients’ medical care to stop the so-called “cytokine storm,” an uncontrolled reaction of the immune system that can have fatal consequences. The drug, which is commonly used to treat other conditions such as psoriasis and rheumatoid … Continue reading Cuba uses monoclonal antibody to control “cytokine storm” in COVID-19 patients